Table 2.
Univariate analysis | Multivariate analysis# | |||
Hazard ratio (95%CI) | p | Hazard ratio (95%CI) | p | |
Histological grade (1 vs. 2 vs. 3) | 3.14 (1.37–7.17) | 0.007 | 0.94 (0.36–2.42) | 0.9 |
Tumor size (≤ 20 mm vs. ≥ 20 mm) | 2.18 (1.27–3.75) | 0.005 | 1.58(0.83–3) | 0.2 |
Nodal status (positive vs. negative) | 1.62 (0.95–2.79) | 0.08 | 1.30 (0.71–2.37) | 0.4 |
ER high vs. low expression | 0.86 (1.18–0.522) | 0.5 | 0.97 (0.56–1.7) | 0.9 |
PgR high vs. low expression | 0.42 (0.25–0.7) | 0.0007 | 0.49 (0.26–0.9) | 0.02 |
HER2 high vs. low expression | 0.88 (0.55–1.42) | 0.6 | 0.66 (0.37–1.18) | 0.2 |
13 cluster gene classifier* | 3.86 (2.32–6.41) | <0.0001 | 3.26 (1.76–6.05) | 0.0002 |
#Multivariate model contained included 210 patients due to missing values, stratified by population.
*Binary classification using leave-one-out cross-validation.
**Age was not included in the model as 92% of patients were ≥ 50 years of age.
ER: estrogen receptor status represented by ESR1 Affymetrix probe set 205225_at.
PgR: progesterone receptor status represented by PGR Affymetrix probe set 208305_at.
HER2: represented by ERBB2 Affymetrix probe set 216836_s_at.
For ER, PgR and HER2, high vs. low expression groups was defined by generating groups at the median value.